Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Autoimmune Disorders

Free Subscription 30.12.2018 2 BMC Neurol 1 Diabet Med 4 Diabetes 1 J Autoimmun 1 J Clin Endocrinol Metab 3 J Neuroimmunol 4 J Neurol 1 J Pediatr 1 N Engl J Med 1 Nat Rev Neurol 2 Neurol Clin Pract 2 Neurology 4 PLoS One 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

BMC Neurol

1. HONG D, Yu Y, Wang Y, Xu Y, et al
   Acute-onset multiple acyl-CoA dehydrogenase deficiency mimicking Guillain-Barre syndrome: two cases report.
   BMC Neurol. 2018;18:219.
   PubMed     Text format     Abstract available
   
   
2. MATIAS-GUIU JA, Cortes-Martinez A, Montero P, Pytel V, et al
   Structural MRI correlates of PASAT performance in multiple sclerosis.
   BMC Neurol. 2018;18:214.
   PubMed     Text format     Abstract available
   
   

   
   Diabet Med

3. ALAM U, Jeziorska M, Petropoulos IN, Pritchard N, et al
   Latent autoimmune diabetes of adulthood (LADA) is associated with small fibre neuropathy.
   Diabet Med. 2018 Dec 21. doi: 10.1111/dme.13888.
   PubMed     Text format     Abstract available
   
   

   
   Diabetes

4. WILSON CS, Chhabra P, Marshall AF, Morr CV, et al
   Healthy Donor Polyclonal IgMs Diminish B-Lymphocyte Autoreactivity, Enhance Regulatory T-Cell Generation, and Reverse Type 1 Diabetes in NOD Mice.
   Diabetes. 2018;67:2349-2360.
   PubMed     Text format     Abstract available
   
   
5. HORWITZ E, Krogvold L, Zhitomirsky S, Swisa A, et al
   Beta Cell DNA Damage Response Promotes Islet Inflammation in Type 1 Diabetes.
   Diabetes. 2018 Aug 27. pii: db17-1006. doi: 10.2337/db17-1006.
   PubMed     Text format     Abstract available
   
   
6. BUITINGA M, Callebaut A, Marques Camara Sodre F, Crevecoeur I, et al
   Inflammation-Induced Citrullinated Glucose-Regulated Protein 78 Elicits Immune Responses in Human Type 1 Diabetes.
   Diabetes. 2018;67:2337-2348.
   PubMed     Text format     Abstract available
   
   
7. CARROLL KR, Elfers EE, Stevens JJ, McNally JP, et al
   Extending Remission and Reversing New Onset Type 1 Diabetes by Targeted Ablation of Autoreactive T Cells.
   Diabetes. 2018 Aug 13. pii: db18-0204. doi: 10.2337/db18-0204.
   PubMed     Text format     Abstract available
   
   

   
   J Autoimmun

8. VILLEGAS JA, Bayer AC, Ider K, Bismuth J, et al
   Il-23/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis.
   J Autoimmun. 2018 Dec 18. pii: S0896-8411(18)30607.
   PubMed     Text format     Abstract available
   
   

   
   J Clin Endocrinol Metab

9. KRAUS AU, Penna-Martinez M, Shoghi F, Seidl C, et al
   HLA-DQB1 pos. 57 defines susceptibility to isolated and polyglandular autoimmunity in adults: interaction with gender.
   J Clin Endocrinol Metab. 2018 Dec 26. pii: 5257820. doi: 10.1210/jc.2018-01621.
   PubMed     Text format     Abstract available
   
   

   
   J Neuroimmunol

10. XIE Y, Li Z, Wang Y, Xue X, et al
    Effects of moderate- versus high- intensity swimming training on inflammatory and CD4(+) T cell subset profiles in experimental autoimmune encephalomyelitis mice.
    J Neuroimmunol. 2018;328:60-67.
    PubMed     Text format     Abstract available
    
    
11. MASOUMI F, Ghorbani S, Talebi F, Branton WG, et al
    Malat1 long noncoding RNA regulates inflammation and leukocyte differentiation in experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2018;328:50-59.
    PubMed     Text format     Abstract available
    
    
12. MEHTA D, Wani S, Wallace L, Henders AK, et al
    Cumulative influence of parity-related genomic changes in multiple sclerosis.
    J Neuroimmunol. 2018;328:38-49.
    PubMed     Text format     Abstract available
    
    

    
    J Neurol

13. BRAUNE S, Grimm S, van Hovell P, Freudensprung U, et al
    Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry.
    J Neurol. 2018;265:2980-2992.
    PubMed     Text format     Abstract available
    
    
14. FALZONE YM, Campagnolo M, Bianco M, Dacci P, et al
    Functioning and quality of life in patients with neuropathy associated with anti-MAG antibodies.
    J Neurol. 2018;265:2927-2933.
    PubMed     Text format     Abstract available
    
    
15. DORST J, Ludolph AC, Senel M, Tumani H, et al
    Short-term and long-term effects of immunoadsorption in refractory chronic inflammatory demyelinating polyneuropathy: a prospective study in 17 patients.
    J Neurol. 2018;265:2906-2915.
    PubMed     Text format     Abstract available
    
    
16. SONG J, Westerlind H, McKay KA, Almqvist C, et al
    Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide study.
    J Neurol. 2018 Dec 21. pii: 10.1007/s00415-018-9163.
    PubMed     Text format     Abstract available
    
    

    
    J Pediatr

17. LAMBERT MP
    Intravenous immunoglobulin use in children with ITP does not affect development of chronic disease.
    J Pediatr. 2019;204:320-323.
    PubMed     Text format    
    
    

    
    N Engl J Med

18. SEIKRIT C, Ronco P, Debiec H
    Factor H Autoantibodies and Membranous Nephropathy.
    N Engl J Med. 2018;379:2479-2481.
    PubMed     Text format    
    
    

    
    Nat Rev Neurol

19. DALAKAS MC
    Immunotherapy in myasthenia gravis in the era of biologics.
    Nat Rev Neurol. 2018 Dec 20. pii: 10.1038/s41582-018-0110.
    PubMed     Text format     Abstract available
    
    

    
    Neurol Clin Pract

20. NOVO AM, Batista S, Alves C, d'Almeida OC, et al
    The neural basis of fatigue in multiple sclerosis: A multimodal MRI approach.
    Neurol Clin Pract. 2018;8:492-500.
    PubMed     Text format     Abstract available
    
    
21. FITZGERALD KC, Salter A, Tyry T, Fox RJ, et al
    Pseudobulbar affect: Prevalence and association with symptoms in multiple sclerosis.
    Neurol Clin Pract. 2018;8:472-481.
    PubMed     Text format     Abstract available
    
    

    
    Neurology

22. PAPPOLLA A, Midaglia L, Boix Rodriguez CP, Puig AA, et al
    Simultaneous CMV and Listeria infection following alemtuzumab treatment for multiple sclerosis.
    Neurology. 2018 Dec 26. pii: WNL.0000000000006801.
    PubMed     Text format    
    
    
23. GASPERINI C, Prosperini L, Tintore M, Sormani MP, et al
    Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.
    Neurology. 2018 Dec 26. pii: WNL.0000000000006810.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

24. ABE K, Takahashi A, Fujita M, Imaizumi H, et al
    Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease.
    PLoS One. 2018;13:e0198757.
    PubMed     Text format     Abstract available
    
    
25. WILLERS C, Iderberg H, Axelsen M, Dahlstrom T, et al
    Sociodemographic determinants and health outcome variation in individuals with type 1 diabetes mellitus: A register-based study.
    PLoS One. 2018;13:e0199170.
    PubMed     Text format     Abstract available
    
    
26. LANATA CM, Nititham J, Taylor KE, Chung SA, et al
    Genetic contributions to lupus nephritis in a multi-ethnic cohort of systemic lupus erythematous patients.
    PLoS One. 2018;13:e0199003.
    PubMed     Text format     Abstract available
    
    
27. HAIDER MZ, Rasoul MA, Al-Mahdi M, Al-Kandari H, et al
    Association of protein tyrosine phosphatase non-receptor type 22 gene functional variant C1858T, HLA-DQ/DR genotypes and autoantibodies with susceptibility to type-1 diabetes mellitus in Kuwaiti Arabs.
    PLoS One. 2018;13:e0198652.
    PubMed     Text format     Abstract available
    
    

    
    Thyroid

28. GUO Q, Wu D, Yu H, Bao J, et al
    Alterations of Global DNA Methylation and DNA Methyltransferase Expression in T and B Lymphocytes from Patients with Newly Diagnosed Autoimmune Thyroid Diseases After Treatment: A Follow-Up Study.
    Thyroid. 2018;28:377-385.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: